Free Access
| Issue |
Med Sci (Paris)
Volume 29, Number 1, Janvier 2013
|
|
|---|---|---|
| Page(s) | 101 - 103 | |
| Section | Forum | |
| DOI | https://doi.org/10.1051/medsci/2013291021 | |
| Published online | 25 January 2013 | |
- Cassier M, Stoppa-Lyonnet D. Un juge fédéral et le gouvernement des États-Unis interviennent contre la brevetabilité des gènes. Med Sci (Paris) 2012 ; 28 : 11–15. [CrossRef] [EDP Sciences] [Google Scholar]
- Cook-Deegan R, Conley JM, Evans JP, Vorhaus D. The next controversy in genetic testing: clinical data as trade secrets? Eu sequence variants of unknownrJ Hum Genet 2012 ; 14 novembre (online). doi: 10.1038/ejhg.2012.217. [Google Scholar]
- Bell CJ, Dinwiddie DL, Miller NA, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011 ; 12 : 65ra4. [CrossRef] [Google Scholar]
- Bale S, Devisscher M, Criekinge WV, et al. MutaDATABASE: a centralized and standardized DNA variation database. Nat Biotechnol 2011 ; 29 : 117–118. [CrossRef] [PubMed] [Google Scholar]
- Donis-Keller H, Green P, Helms C, et al.A genetic linkage map of the human genome. Cell 1987 ; 51 : 319–337. [CrossRef] [PubMed] [Google Scholar]
- Weissenbach J. A second generation linkage map of the human genome based on highly informative microsatellite loci. Gene 1993 ; 135 : 275–278. [CrossRef] [PubMed] [Google Scholar]
- Cassier M, Stoppa-Lyonnet D. L’opposition contre les brevets de Myriad Genetics et leur révocation totale ou partielle en Europe : premiers enseignements. Med Sci (Paris) 2005 ; 21 : 658–662. [Google Scholar]
- Myriad Genetics’ Q4 revenues rise 24 percent. Ramp up of european operations continues. GenomeWeb Daily News, August 15, 2012. [Google Scholar]
- Easton DF, Deffenbaugh AM, Pruss D, et al. A systematic genetic assessment of 1, 433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 2007 ; 81 : 873–883. [CrossRef] [PubMed] [Google Scholar]
- Spurdle AB, Healey S, Devereau A, et al. ENIGMA-evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat 2012 ; 33 : 2–7. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.